Selima Pharmaceuticals Email Formats

Pharmaceutical Manufacturing • Sydney, New South Wales, Australia • 1-10 Employees

Key Contact at Selima Pharmaceuticals

Dr Sam Megalli

Chief Executive Officer

Company overview

Headquarters	Sydney, New South Wales, Australia
Phone number	+61296449893
Website	selimapharma.com.au
NAICS	3254
SIC	512
Keywords	Pharmaceuticals Distribution, Pharmaceuticals Development, Pharmaceuticals Manufacture
Founded	2019
Employees	1-10

About Selima Pharmaceuticals

Selima Pharmaceuticals is an Australian Owned Pharmaceutical company based is Sydney, Australia. We specialise in the research, development, marketing and distribution of pharmaceutical products. All our products are proudly Made in Australia.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Selima Pharmaceuticals has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Selima Pharmaceuticals has never raised funding before.

Selima Pharmaceuticals Tech Stack

Discover the technologies and tools that power Selima Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Elementor

Page builders

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Nginx

Reverse proxies

PHP

Programming languages

Open Graph

Miscellaneous

Site Kit

Analytics

WordPress

Blogs

core-js

JavaScript libraries

RankMath SEO

SEO

Google Analytics

Analytics

jQuery UI

JavaScript libraries

Frequently asked questions

Selima Pharmaceuticals is located in Sydney, New South Wales, AU.

You can reach Selima Pharmaceuticals at +61296449893.

Selima Pharmaceuticals was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Selima Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Selima Pharmaceuticals

Dr Sam Megalli

Chief Executive Officer

4.8

40,000 users